Lyophilized symbiotic mitigates mucositis induced by 5-fluorouracil
| dc.creator | Bruna Machado Savassi | |
| dc.creator | Bárbara Fernandes Cordeiro | |
| dc.creator | Sara Heloisa da Silva | |
| dc.creator | Emiliano Rosa Oliveira | |
| dc.creator | Giovanna Belo | |
| dc.creator | Alessandra Gomes Figueiroa | |
| dc.creator | Maria Izabel Alves Queiroz | |
| dc.creator | Ana Maria Caetano Faria | |
| dc.creator | Juliana Alves | |
| dc.creator | Tales Fernando da Silva | |
| dc.creator | Gabriela Munis Campos | |
| dc.creator | Erick Almeida Esmerino | |
| dc.creator | Ramon da Silva Rocha | |
| dc.creator | Mônica Queiroz de Freitas | |
| dc.creator | Marcia Cristina Silva | |
| dc.creator | Adriano Gomes da Cruz | |
| dc.creator | Kátia Duarte Vital | |
| dc.creator | Simone Odília Antunes Fernandes | |
| dc.creator | Valbert Nascimento Cardoso | |
| dc.creator | Leonardo Borges Arcucio | |
| dc.creator | Gwénaël Jan | |
| dc.creator | Yves Le Loir | |
| dc.creator | Alfonso Gala-Garcia | |
| dc.creator | Fillipe Luiz Rosa do Carmo | |
| dc.creator | Vasco Azevedo | |
| dc.date.accessioned | 2023-04-03T20:54:57Z | |
| dc.date.accessioned | 2025-09-08T23:01:29Z | |
| dc.date.available | 2023-04-03T20:54:57Z | |
| dc.date.issued | 2021-12-10 | |
| dc.description.sponsorship | CNPq - Conselho Nacional de Desenvolvimento Científico e Tecnológico | |
| dc.description.sponsorship | FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais | |
| dc.description.sponsorship | CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.3389/fphar.2021.755871 | |
| dc.identifier.issn | 16639812 | |
| dc.identifier.uri | https://hdl.handle.net/1843/51519 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Frontiers in Pharmacology | |
| dc.rights | Acesso Aberto | |
| dc.subject | Mucosite | |
| dc.subject | 5-Fluorouracil | |
| dc.subject | Probiótico | |
| dc.subject | Prebiótico | |
| dc.subject.other | Probiotic | |
| dc.subject.other | Chemotherapy | |
| dc.subject.other | Prebiotic | |
| dc.subject.other | Immunomodulant effects | |
| dc.subject.other | Symbiotic | |
| dc.title | Lyophilized symbiotic mitigates mucositis induced by 5-fluorouracil | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 12 | |
| local.citation.spage | 1 | |
| local.citation.volume | 12 | |
| local.description.resumo | Mucositis is an adverse effect of cancer chemotherapies using 5-Fluorouracil (5-FU). It is characterized by mucosal inflammation, pain, diarrhea, and weight loss. Some studies reported promising healing effects of probiotic strains, when associated with prebiotics, as adjuvant treatment of mucositis. We developed a lyophilized symbiotic product, containing skimmed milk, supplemented with whey protein isolate (WPI) and with fructooligosaccharides (FOS), and fermented by Lactobacillus casei BL23, Lactiplantibacillus plantarum B7, and Lacticaseibacillus rhamnosus B1. In a mice 5-FU mucositis model, this symbiotic lyophilized formulation was able to reduce weight loss and intestinal permeability. This last was determined in vivo by quantifying blood radioactivity after oral administration of 99mTc-DTPA. Finally, histological damages caused by 5-FU-induced mucositis were monitored. Consumption of the symbiotic formulation caused a reduced score of inflammation in the duodenum, ileum, and colon. In addition, it decreased levels of pro-inflammatory cytokines IL-1β, IL-6, IL-17, and TNF-α in the mice ileum. The symbiotic product developed in this work thus represents a promising adjuvant treatment of mucositis. | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ALIMENTOS | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | ICB - DEPARTAMENTO DE BIOQUÍMICA E IMUNOLOGIA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.frontiersin.org/articles/10.3389/fphar.2021.755871/full |